• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Tuberculosis annual report 2009 --series 10. Treatment outcome and TB deaths].

出版信息

Kekkaku. 2012 May;87(5):415-9.

PMID:22696774
Abstract

Evaluation of the treatment outcome by the cohort analysis method is an important part of tuberculosis (TB) control. In the Japanese TB surveillance system, the treatment outcome is automatically classified by computer according to a pre-set algorithm, so the treatment outcome is evaluated very rigidly. In the case of new sputum smear positive pulmonary TB cases (n = 8,999) newly notified in 2008, the patients' treatment outcomes based on the annual report 2009 database were as follows: "success," which combined "cured" and "completed," was 47.7%, "died" was 19.1%, "failed" was 1.1%, "defaulted" was 3.8%, "transferred out" was 2.8%, "on treatment after 12 months" was 11.8% and "not evaluated" was 13.6%. In addition to evaluation of the treatment outcome by the cohort method, the proportion of deaths was observed among all forms of TB patients (n = 24,571) who were newly registered in 2008. In total, 17.3% of all forms of TB cases died within one year after the beginning of treatment. The proportion corresponding to this was 23.7% for new sputum smear positive pulmonary TB and 23.5% for re-treatment sputum smear positive pulmonary TB. Among the new sputum smear positive pulmonary TB patients (n = 2,136) who died within one year after the beginning of treatment, 37.0% of them died within one month after the beginning of treatment, 51.6% died within two months and 61.9% died within three months.

摘要

相似文献

1
[Tuberculosis annual report 2009 --series 10. Treatment outcome and TB deaths].
Kekkaku. 2012 May;87(5):415-9.
2
[Tuberculosis annual report 2008--series 10. Treatment outcome and TB deaths].
Kekkaku. 2010 Aug;85(8):683-6.
3
[Tuberculosis Annual Report 2011--(4) Tuberculosis treatment and treatment outcomes].《2011年结核病年度报告 --(4)结核病治疗与治疗结果》
Kekkaku. 2013 Sep;88(9):677-86.
4
[Tuberculosis annual report 2009--series 9. Treatment of TB (2)].《2009年结核病年度报告——第9辑. 结核病治疗(2)》
Kekkaku. 2012 Apr;87(4):351-5.
5
[Tuberuculosis annual report 2010 (10)--treatment outcomes].《2010年结核病年度报告(10)——治疗结果》
Kekkaku. 2013 May;88(5):491-5.
6
[The first-three year report of the Tuberculosis Control Project, Lumbini, Rupandehi].[蓝毗尼、鲁潘德希结核病控制项目头三年报告]
Kekkaku. 1998 Dec;73(12):697-703.
7
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].[耐异烟肼或耐利福平结核病的特征及治疗结果]
Kekkaku. 2003 Oct;78(10):611-7.
8
[TUBERCULOSIS ANNUAL REPORT 2013--(4) Tuberculosis Treatment and Treatment Outcomes].《2013年结核病年度报告--(4)结核病治疗与治疗结果》
Kekkaku. 2015 Jul;90(7):595-604.
9
[Tuberculosis Annual Report 2008--Series 9. Treatment of TB (2)].《2008年结核病年度报告——第9辑. 结核病治疗(2)》
Kekkaku. 2010 Jul;85(7):643-6.
10
[Tuberculosis annual report 2012--(4) Tuberculosis treatment and outcomes].《2012年结核病年度报告--(4)结核病治疗与转归》
Kekkaku. 2014 Dec;89(12):825-34.